10 AI News and Ratings You Should Not Miss

5. Gilead Sciences, Inc. (NASDAQ:GILD)

Number of Hedge Fund Holders: 59

Gilead Sciences, Inc. (NASDAQ:GILD) develops and markets medicines for HIV, COVID-19, hepatitis, cancer, and other serious conditions.

On January 30, Gilead Sciences, Inc. (NASDAQ:GILD) and Cognizant announced that they expanded their partnership to improve the biopharmaceutical company’s productivity and cost-efficiency through AI and advanced technologies. The collaboration focuses on using machine learning and generative AI across different functions, including customer service, employee interactions, and business value management.

Cognizant aims to improve Gilead’s operations and financial framework and ultimately provide significant cost savings that can be reinvested into its core business of developing life-saving treatments. Their expanded partnership builds on their decade-long collaboration, with Cognizant deploying its Neuro AI platform to accelerate value creation and improve IT and business processes.